1. Home
  2. BMRN vs PR Comparison

BMRN vs PR Comparison

Compare BMRN & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • PR
  • Stock Information
  • Founded
  • BMRN 1996
  • PR 2015
  • Country
  • BMRN United States
  • PR United States
  • Employees
  • BMRN N/A
  • PR N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • PR Oil & Gas Production
  • Sector
  • BMRN Health Care
  • PR Energy
  • Exchange
  • BMRN Nasdaq
  • PR Nasdaq
  • Market Cap
  • BMRN 11.1B
  • PR 9.9B
  • IPO Year
  • BMRN 1999
  • PR 2016
  • Fundamental
  • Price
  • BMRN $54.09
  • PR $13.69
  • Analyst Decision
  • BMRN Buy
  • PR Strong Buy
  • Analyst Count
  • BMRN 24
  • PR 14
  • Target Price
  • BMRN $91.70
  • PR $18.08
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • PR 9.1M
  • Earning Date
  • BMRN 10-28-2025
  • PR 11-05-2025
  • Dividend Yield
  • BMRN N/A
  • PR 4.38%
  • EPS Growth
  • BMRN 154.69
  • PR 18.42
  • EPS
  • BMRN 3.40
  • PR 1.54
  • Revenue
  • BMRN $3,063,608,000.00
  • PR $5,085,699,000.00
  • Revenue This Year
  • BMRN $13.32
  • PR $7.44
  • Revenue Next Year
  • BMRN $9.37
  • PR $1.60
  • P/E Ratio
  • BMRN $15.91
  • PR $8.92
  • Revenue Growth
  • BMRN 18.36
  • PR 16.37
  • 52 Week Low
  • BMRN $52.93
  • PR $10.01
  • 52 Week High
  • BMRN $85.00
  • PR $16.33
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 37.63
  • PR 47.79
  • Support Level
  • BMRN $55.99
  • PR $13.71
  • Resistance Level
  • BMRN $59.79
  • PR $14.23
  • Average True Range (ATR)
  • BMRN 1.57
  • PR 0.47
  • MACD
  • BMRN -0.40
  • PR -0.02
  • Stochastic Oscillator
  • BMRN 0.70
  • PR 13.16

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: